Reducing Dietary Fibre & Constipation

Key findings

• •Adults with chronic constipation were allocated to: continue high‑fibre intake, substantially reduce fibre, or stop fibre as far as practical.
• •Those who stopped fibre had the greatest improvements in stool frequency, bloating and straining.
• •The reduced‑fibre group also improved, but less dramatically; the high‑fibre group had minimal change.
• •Primary outcomes were directly observable clinical symptoms, not lab markers.
• •The study is prospective but small, with limited detailing of randomisation and blinding.

Background

• •High‑fibre diets are often recommended almost automatically for constipation. Yet some patients report that fibre makes their symptoms worse. Ho and colleagues asked: What happens to constipation symptoms when people with chronic constipation reduce or stop dietary fibre compared with continuing a high‑fibre diet?

Methods

• •Participants: adults diagnosed with chronic constipation. Groups: High‑fibre group (continued their usual high‑fibre diet), Reduced‑fibre group (lowered fibre intake substantially), No‑fibre group (stopped fibre as far as practically possible). Duration: several weeks of follow‑up. Endpoints (hard, clinically relevant): bowel movement frequency, straining during defecation, abdominal bloating and pain, need for laxatives.

Results

• •No‑fibre group: reported the largest increase in spontaneous bowel movements, had marked reductions in straining and bloating, often no longer relied on laxatives. Reduced‑fibre group: symptoms improved, but less than in the no‑fibre group. High‑fibre group: showed minimal improvement; many remained constipated with ongoing bloating.

Interpretation

• •For WorthDay, S05 is a rare human intervention testing a widely accepted lifestyle recommendation: It suggests that in people already constipated, high fibre can worsen or sustain symptoms, while reducing or eliminating fibre can relieve them. Because: the sample is small, randomisation and blinding are limited, WorthDay scores this as 🟡 moderate evidence: strong enough to question blanket fibre prescriptions, but not definitive for all contexts.

Limitations

• •Small sample size; results may not generalise to all populations.
• •Allocation and blinding procedures are not as rigorous as modern large RCTs.
• •Dietary adherence and exact fibre amounts depend partly on self‑report.
• •Only chronic constipation patients were studied; results do not imply that fibre is harmful in all people.
• •Different fibre types (soluble vs insoluble) were not separated.

WorthDay perspective

• •S05 fits WorthDay's critical approach to "one‑size‑fits‑all" advice: "For some chronically constipated people, less or even no fibre improved symptoms substantially, while high‑fibre intake kept them constipated."
• •WorthDay can: encourage users with longstanding constipation to experiment with fibre reduction (ideally under medical guidance), use the Science Lab entry to show how even strong mainstream beliefs can be challenged by simple data.
• •Health and Foodlovers activities might include: trial periods with minimal added fibre supplements and grain products, careful logging of stool frequency, ease and comfort.

Notes

Prospective intervention study in adults with chronic constipation (Ho et al. 2012): continue high fibre vs reduce fibre vs stop fibre over several weeks. Hard clinical symptom endpoints: bowel movement frequency, straining, bloating and pain, laxative need. The zero-fibre group improved most, the reduced-fibre group intermediately, the high-fibre group showed minimal change. Small sample, limited randomisation and blinding, adherence partly self-reported. Moderate evidence (🟡).